Hydroxyamine

Hydroxyamine

SCHEMBL5268858

CCCc1cc(C(=O)N2CCC2C(=O)O)cc(OC(F)(F)F)c1OC.NO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 2/20 0.36
PKM P14618 1/20 0.36
PDE4D Q08499 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyamine SCHEMBL5268861 1.00 PDE4B (0.39) PDE4BL3MBTL1ALDH1A1PKMPDE4D
SCHEMBL3550102 0.89 PDK2 (0.43) PDE4BALDH1A1PDE4D
SCHEMBL3550103 0.89 PDK2 (0.43) PDE4BALDH1A1PDE4D
SCHEMBL3544576 0.88 MMP2 (0.36) PDE4BALDH1A1PDE4D
SCHEMBL3544577 0.88 MMP2 (0.36) PDE4BALDH1A1PDE4D
Hydroxyamine SCHEMBL3621021 0.79 ALDH1A1 (0.47) L3MBTL1ALDH1A1LMNA
SCHEMBL3544265 0.79 FKBP1A (0.51) ALDH1A1GAA
Hydroxyamine SCHEMBL3621023 0.79 ALDH1A1 (0.47) L3MBTL1ALDH1A1LMNA
SCHEMBL3544267 0.79 FKBP1A (0.51) ALDH1A1GAA
Hydroxyamine SCHEMBL5274861 0.78 GAA (0.53) L3MBTL1ALDH1A1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539744-A4 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARM INC (US) 2007-06-06 EP disclosed
EP-1539744-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2005-06-15 EP disclosed
WO-2004007444-A2 N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2004-01-22 WO disclosed